↓ Skip to main content

Nucleic Acid–Based Therapeutics for Parkinson's Disease

Overview of attention for article published in Neurotherapeutics, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
2 X users
patent
2 patents

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
72 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Nucleic Acid–Based Therapeutics for Parkinson's Disease
Published in
Neurotherapeutics, April 2019
DOI 10.1007/s13311-019-00714-7
Pubmed ID
Authors

Masayuki Nakamori, Eunsung Junn, Hideki Mochizuki, M Maral Mouradian

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 19%
Student > Bachelor 9 13%
Researcher 8 11%
Student > Doctoral Student 6 8%
Student > Master 4 6%
Other 7 10%
Unknown 24 33%
Readers by discipline Count As %
Medicine and Dentistry 9 13%
Pharmacology, Toxicology and Pharmaceutical Science 8 11%
Biochemistry, Genetics and Molecular Biology 8 11%
Neuroscience 8 11%
Agricultural and Biological Sciences 2 3%
Other 7 10%
Unknown 30 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2024.
All research outputs
#5,304,202
of 25,613,746 outputs
Outputs from Neurotherapeutics
#561
of 1,312 outputs
Outputs of similar age
#103,159
of 365,105 outputs
Outputs of similar age from Neurotherapeutics
#5
of 14 outputs
Altmetric has tracked 25,613,746 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,312 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.4. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,105 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.